Cargando…
Design, synthesis, and biological evaluation of pyrido[2,3-d]pyrimidine and thieno[2,3-d]pyrimidine derivatives as novel EGFR(L858R/T790M) inhibitors
EGFR mutations have been identified in 20,000 reported NSCLC (non-small cell lung cancer) samples, and exon 19 deletions and L858R mutations at position 21, known as “classical” mutations, account for 85–90% of the total EGFR (epidermal growth factor receptor) mutations. In this paper, two series of...
Autores principales: | Fu, Jianfang, Yu, Jie, Zhang, Xiang, Chang, Yaoyao, Fan, Hongze, Dong, Mengzhen, Li, Mengjia, Liu, Yue, Hu, Jinxing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150624/ https://www.ncbi.nlm.nih.gov/pubmed/37106478 http://dx.doi.org/10.1080/14756366.2023.2205605 |
Ejemplares similares
-
Pyridine-Based Heterocycles. Synthesis of New Pyrido [4',3':4,5]thieno[2,3-d]pyrimidines and Related Heterocycles
por: El-Kashef, Hussein, et al.
Publicado: (2010) -
Medicinal chemistry perspective of pyrido[2,3-d]pyrimidines as anticancer agents
por: Kumar, Adarsh, et al.
Publicado: (2023) -
Synthesis, Characterization and Biological Studies of Some Novel Thieno[2,3-d]pyrimidines
por: Al-Taisan, Khulud M., et al.
Publicado: (2010) -
3,5,6-Trimethylthieno[2,3-d]pyrimidin-4(3H)-one
por: Khatamov, Khamroqul, et al.
Publicado: (2012) -
Pyrido[2,3-d]pyrimidin-7(8H)-ones: Synthesis and Biomedical Applications
por: Jubete, Guillem, et al.
Publicado: (2019)